1. Home
  2. RLMD vs LFWD Comparison

RLMD vs LFWD Comparison

Compare RLMD & LFWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • LFWD
  • Stock Information
  • Founded
  • RLMD 2004
  • LFWD 2001
  • Country
  • RLMD United States
  • LFWD Israel
  • Employees
  • RLMD N/A
  • LFWD N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • LFWD
  • Sector
  • RLMD Health Care
  • LFWD
  • Exchange
  • RLMD Nasdaq
  • LFWD NYSE
  • Market Cap
  • RLMD 11.5M
  • LFWD 13.7M
  • IPO Year
  • RLMD N/A
  • LFWD 2014
  • Fundamental
  • Price
  • RLMD $0.38
  • LFWD $1.53
  • Analyst Decision
  • RLMD Hold
  • LFWD Strong Buy
  • Analyst Count
  • RLMD 4
  • LFWD 1
  • Target Price
  • RLMD $4.25
  • LFWD $13.00
  • AVG Volume (30 Days)
  • RLMD 881.7K
  • LFWD 696.5K
  • Earning Date
  • RLMD 03-18-2025
  • LFWD 02-25-2025
  • Dividend Yield
  • RLMD N/A
  • LFWD N/A
  • EPS Growth
  • RLMD N/A
  • LFWD N/A
  • EPS
  • RLMD N/A
  • LFWD N/A
  • Revenue
  • RLMD N/A
  • LFWD $25,002,000.00
  • Revenue This Year
  • RLMD N/A
  • LFWD $87.01
  • Revenue Next Year
  • RLMD N/A
  • LFWD $47.64
  • P/E Ratio
  • RLMD N/A
  • LFWD N/A
  • Revenue Growth
  • RLMD N/A
  • LFWD 173.28
  • 52 Week Low
  • RLMD $0.34
  • LFWD $1.41
  • 52 Week High
  • RLMD $7.22
  • LFWD $7.84
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 27.23
  • LFWD 43.19
  • Support Level
  • RLMD $0.36
  • LFWD $1.83
  • Resistance Level
  • RLMD $0.49
  • LFWD $4.00
  • Average True Range (ATR)
  • RLMD 0.04
  • LFWD 0.35
  • MACD
  • RLMD 0.07
  • LFWD -0.05
  • Stochastic Oscillator
  • RLMD 12.64
  • LFWD 2.75

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About LFWD REWALK ROBOTICS LTD

Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.

Share on Social Networks: